Sheehan's syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
Line 55: Line 55:


* Most senitive test is low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH.]]
* Most senitive test is low baseline [[prolactin]] levels w/o response to [[Thyrotropin-releasing hormone|TRH.]]
|CT/MRI shows sequential changes of pituitary enlargement followed by shrinkage and necrosis leading to decreased sellar volume or empty sella.
|CT/MRI shows sequential changes of pituitary enlargement followed by shrinkage and [[necrosis]] leading to decreased sellar volume or [[empty sella]].
|Pituitary hormone stimulation tests(Metoclopramide and clomiphene citrate stimulation tests)
|Pituitary hormone stimulation tests
([[Metoclopramide]] and [[clomiphene citrate]] stimulation tests)
|-
|-
|[[Pituitary apoplexy]]
|[[Pituitary apoplexy]]
Line 75: Line 76:
|MRI
|MRI
|
|
* [[CT]] scan without [[Contrast medium|contrast]] is the initial test of choice. [[Pituitary hemorrhage|Pituitary hemorrhag]]<nowiki/>e on [[CT]] presents as a hyper-dense lesion.
* [[CT]] scan without [[Contrast medium|contrast]] is the initial test of choice. [[Pituitary hemorrhage|Pituitary hemorrhag]]<nowiki/>e on [[CT]] presents as a hyperdense lesion.


* [[MRI]] is done in cases of inconclusive [[CT]].  
* [[MRI]] is done in cases of inconclusive [[CT]].  
Line 98: Line 99:
* Mass lesion effect such as [[Visual field defect|visual field defects]]
* Mass lesion effect such as [[Visual field defect|visual field defects]]
|
|
* DI
* [[Diabetes insipidus|DI]]


* Autoimmune thyroiditis
* [[Autoimmune]] [[thyroiditis]]
|
|
* Decreased pituitary hormones(Gonadotropins most common)
* Decreased pituitary hormones([[Gonadotropins]] most common)


* Hyperprolactinemia(40%)
* [[Hyperprolactinemia]](40%)


* GH excess
* [[Growth hormone|GH]] excess
|The most accurate test is a [[Pituitary gland|pituitary]][[biopsy]] which will show [[lymphocytic]][[Infiltration (medical)|infiltration]].
|The most accurate test is a [[Pituitary gland|pituitary]][[biopsy]] which will show [[lymphocytic]][[Infiltration (medical)|infiltration]].
|
|
Line 112: Line 113:


* Diffuse and homogeneous contrast enhancement
* Diffuse and homogeneous contrast enhancement
|Assays for anti-TPO and anti-Tg Ab
|[[Assay|Assays]] for anti-TPO and anti-Tg Ab
|-
|-
|[[Subarachnoid hemorrhage]]
|[[Subarachnoid hemorrhage]]
Line 125: Line 126:
* [[Nausea]] and [[vomiting]]
* [[Nausea]] and [[vomiting]]
* Symptoms of [[meningeal irritation]]
* Symptoms of [[meningeal irritation]]
|Signs of meningeal irritation
|Signs of [[meningeal irritation]]


|Xanthochromia
|[[Xanthochromic|Xanthochromia]]
|[[Digital subtraction angiography]]
|[[Digital subtraction angiography]]
|
|
Line 144: Line 145:
|Oligo/amenorrhea
|Oligo/amenorrhea
|
|
* Erectile dysfunction
* [[Erectile dysfunction]]


* Headache
* [[Headache]]


* Low libido
* Low [[libido]]


|
|
* Signs of raised intracranial pressure may be present
* Signs of raised [[intracranial pressure]] may be present


* Nipple discharge
* [[Nipple discharge|Nipple]] discharge
|Decreased levels of  pituitary hormones in blood.
|Decreased levels of  pituitary hormones in blood.
|MRI
|MRI
|Empty sella containing CSF  
|[[Empty sella]] containing [[Cerebrospinal fluid|CSF]]
|Pituitary hormone stimulation tests(Metoclopramide and clomiphene citrate stimulation tests)
|Pituitary hormone stimulation tests(Metoclopramide and clomiphene citrate stimulation tests)
|-
|-
Line 165: Line 166:
|Oligo/amenorrhea
|Oligo/amenorrhea
|
|
* Cachexia
* [[Cachexia]]
 
* [[Premature aging|Premature]] aging
* Premature aging
|
|
* Progressive emaciation
* Progressive [[emaciation]]


* Loss of body hair
* Loss of body hair
Line 181: Line 181:
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|Oligomenorrhea/menorrhagia
|Oligomenorrhea/[[menorrhagia]]
|
|
* Cold intolerance
* Cold intolerance
* Constipation
* [[Constipation]]
|
|
* Dry skin
* Dry skin


* Bradycardia
* [[Bradycardia]]


* Hair loss
* Hair loss


* Myxedema
* [[Myxedema]]


* Delayed relaxation phase of deep tendon reflexes
* Delayed relaxation phase of deep [[Tendon reflex|tendon reflexes]]
|
|
* Low T3,T4
* Low [[T3]],[[T4]]


* High TSH
* High [[Thyroid-stimulating hormone|TSH]]


* Rest of pituitary hormone levels WNL
* Rest of pituitary hormone levels WNL
Line 213: Line 213:
|Oligo/amenorrhea
|Oligo/amenorrhea
|
|
* Hot flushes
* [[Hot flushes]]


* Energy and mood changes
* Energy and mood changes


* Decreased libido
* Decreased [[libido]]
|
|
|
|
* Low estrogen, testosterone
* Low [[estrogen]], [[testosterone]]


* High FSH/LH
* High [[FSH]]/[[LH]]
|
|
|
|Done to rule out any pituitary cause
* Done to rule out any pituitary cause
|
|
* Genetic tests  (karyotype)
* Genetic tests  (karyotype)
Line 235: Line 234:
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|Infertility
|[[Infertility]]


Subfertiliy
Subfertiliy
Line 255: Line 254:
|Oligo/amenorrhea
|Oligo/amenorrhea
|
|
* Polyuria
* [[Polyuria]]


* Polydipsia
* [[Polydipsia]]
* Features of hypothyroidism and hypoadrenalism
* Features of [[hypothyroidism]] and [[hypoadrenalism]]
|
|
* Growth failure
* [[Growth failure]]


* B/L hemianopsia
* B/L [[hemianopsia]]


* Papilledema
* [[Papilledema]]
|All pituitary hormones decreased
|All pituitary hormones decreased
|MRI
|MRI
Line 276: Line 275:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
* Hypoglycemia
* [[Hypoglycemia]]


* Hypotension
* [[Hypotension]]
|
|
* Dehydration
* [[Dehydration]]


* Hyperpigmentation
* [[Hyperpigmentation]]


* loss of pubic and axillary hair
* loss of [[pubic]] and [[axillary]] hair


|
|
* Hyponatremia with/without hyperkalemia
* [[Hyponatremia]] with/without [[hyperkalemia]]


* Plasma renin activity to aldosterone ratio
* [[Plasma renin activity]] to [[Aldosterone|aldosterone ratio]]
|CT abdomen
|CT abdomen
|CT abdomen
|CT abdomen
Line 305: Line 304:
|Oligo/amenorrhea
|Oligo/amenorrhea
|
|
* Hot flashes  
* [[Hot flashes]]
* Insomnia
* [[Insomnia]]
* Weight gain and bloating
* [[Weight gain]] and [[bloating]]
* Mood changes
* Mood changes
|
|
* Vaginal atrophy
* [[Vaginal atrophy]]
* Loss of pelvic muscle tone
* Loss of pelvic [[muscle tone]]
|
|
* ↑ FSH
* ↑ [[FSH]]
* ↓ Estradiol and inhibin
* ↓ [[Estradiol]] and [[inhibin]]
|FSH > LH
|[[FSH]] > [[LH]]
|
|
|
|

Revision as of 15:33, 23 August 2017

Sheehan's syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sheehan's syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sheehan's syndrome differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sheehan's syndrome differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sheehan's syndrome differential diagnosis

CDC on Sheehan's syndrome differential diagnosis

Sheehan's syndrome differential diagnosis in the news

Blogs on Sheehan's syndrome differential diagnosis

Directions to Hospitals Treating Sheehan's syndrome

Risk calculators and risk factors for Sheehan's syndrome differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Iqra Qamar M.D.[2]

Overview

Sheehan syndrome must be differentiated from lymphocytic hypophysitis, pituitary apoplexy, hypothyroidism, Addison's disease, panhypopititarism, empty sella syndrome, hypogonadotropic hypogonadism, Simmond's disease, hypoprolactinemia, menopause,female athlete triadand SAH.[1][2][3]

Differentiating Sheehan's Syndrome from other Diseases

Sheehan's syndrome should be differentiated from other diseases causing hypopituitarism.[4][5][6][7][8][9]

Diseases Onset Manifestations Diagnosis
History and Symptoms Physical examination Laboratory findings Gold standard Imaging Other investigation findings
Trumatic delivery Lactation failure Menstrual irregularities Other features
Sheehan's syndrome Acute ++ ++ Oligo/amenorrhea
  • Dx is clinical
  • Most senitive test is low baseline prolactin levels w/o response to TRH.
CT/MRI shows sequential changes of pituitary enlargement followed by shrinkage and necrosis leading to decreased sellar volume or empty sella. Pituitary hormone stimulation tests

(Metoclopramide and clomiphene citrate stimulation tests)

Pituitary apoplexy Acute +/- ++ Oligo/amenorrhea Severe headache Decreased levels of anterior pituitary hormones in blood. MRI
  • MRI is done in cases of inconclusive CT.

Blood tests may be done to check:

Lymphocytic hypophysitis Acute +/- + Oligo/amenorrhea
  • Retro-orbital or Bitemporal pain
The most accurate test is a pituitarybiopsy which will show lymphocyticinfiltration.
  • Diffuse and homogeneous contrast enhancement
Assays for anti-TPO and anti-Tg Ab
Subarachnoid hemorrhage Acute - - - Signs of meningeal irritation Xanthochromia Digital subtraction angiography

Lumbar puncture (LP)  shows:

Empty sella syndrome Chronic - + Oligo/amenorrhea Decreased levels of pituitary hormones in blood. MRI Empty sella containing CSF Pituitary hormone stimulation tests(Metoclopramide and clomiphene citrate stimulation tests)
Simmond's disease/Pituitary chachexia Chronic +/- + Oligo/amenorrhea
  • Loss of body hair
Decreased levels of anterior pituitary hormones in blood. MRI Pituitary hormone stimulation tests(Metoclopramide and clomiphene citrate stimulation tests)
Primary hypothyroidism Chronic +/- - Oligomenorrhea/menorrhagia
  • Dry skin
  • Hair loss
  • Rest of pituitary hormone levels WNL
TSH levels Done to rule out ant pituitary cause
  • Assays for anti-TPO and anti-Tg Ab
  • FNA biopsy
Primary hypogonadotropic hypogonadism Chronic - - Oligo/amenorrhea
  • Energy and mood changes
Done to rule out any pituitary cause
  • Genetic tests  (karyotype)
  • Measurement of total and free testosterone and 17-hydroxyprogesterone concentrations
Hypoprolactinemia Chronic - + - Infertility

Subfertiliy

Puerperal agalactogenesis No workup is necessary Done to rule out any pituitary cause
  • Prolactin assay in 3rd trimester
  • LH, FSH
  • Thyrotropin and free thyroxine
Panhypopituitarism Chronic - + Oligo/amenorrhea All pituitary hormones decreased MRI Left hand and wrist radiograph for bone age
Primary adrenal insufficiency/Addison's disease Chronic - - - CT abdomen CT abdomen
  • Serum cortisol testing
  • Serum ACTH testing
  • Anti-adrenal Ab testing
Menopause Chronic - +/- Oligo/amenorrhea FSH > LH

References

  1. Rolih CA, Ober KP (1993). "Pituitary apoplexy". Endocrinol. Metab. Clin. North Am. 22 (2): 291–302. PMID 8325288.
  2. Vidal E, Cevallos R, Vidal J, Ravon R, Moreau JJ, Rogues AM, Loustaud V, Liozon F (1992). "Twelve cases of pituitary apoplexy". Arch. Intern. Med. 152 (9): 1893–9. PMID 1520058.
  3. Lazaro CM, Guo WY, Sami M, Hindmarsh T, Ericson K, Hulting AL, Wersäll J (1994). "Haemorrhagic pituitary tumours". Neuroradiology. 36 (2): 111–4. PMID 8183446.
  4. Sato N, Sze G, Endo K (1998). "Hypophysitis: endocrinologic and dynamic MR findings". AJNR Am J Neuroradiol. 19 (3): 439–44. PMID 9541295.
  5. Powrie JK, Powell M, Ayers AB, Lowy C, Sönksen PH (1995). "Lymphocytic adenohypophysitis: magnetic resonance imaging features of two new cases and a review of the literature". Clin. Endocrinol. (Oxf). 42 (3): 315–22. PMID 7758238.
  6. Honegger J, Schlaffer S, Menzel C, Droste M, Werner S, Elbelt U, Strasburger C, Störmann S, Küppers A, Streetz-van der Werf C, Deutschbein T, Stieg M, Rotermund R, Milian M, Petersenn S (2015). "Diagnosis of Primary Hypophysitis in Germany". J. Clin. Endocrinol. Metab. 100 (10): 3841–9. doi:10.1210/jc.2015-2152. PMID 26262437.
  7. Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995). "Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings". J. Clin. Endocrinol. Metab. 80 (8): 2302–11. doi:10.1210/jcem.80.8.7629223. PMID 7629223.
  8. Imura H, Nakao K, Shimatsu A, Ogawa Y, Sando T, Fujisawa I, Yamabe H (1993). "Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus". N. Engl. J. Med. 329 (10): 683–9. doi:10.1056/NEJM199309023291002. PMID 8345854.
  9. Hsieh CY, Liu BY, Yang YN, Yin WH, Young MS (2011). "Massive pericardial effusion with diastolic right ventricular compression secondary to hypothyroidism in a 73-year-old woman". Emerg Med Australas. 23 (3): 372–5. doi:10.1111/j.1742-6723.2011.01425.x. PMID 21668725.

Template:WH Template:WS